Skip to main content

About us

Tyris Therapeutics has been founded to design the future of DNA-based treatments for patients suffering from life threatening diseases.

Tyris Therapeutics was founded by Columbus Venture Partners to transform DNA-based therapies with unique DNA format (oDNA™) and innovative Non-Viral delivery

Expanding the reach of gene therapies is our mission

Tyris objective is to provide the next generation of non-viral gene therapies for every patient, for any diseases whatever the size of the gene(s) involved, providing a safer and lifelong control of the disease through drug titration and redosing.

And transforming the life of patients is our driver

With that purpose in mind, our experienced team of talented scientists is passionate on discovering and developing the next generation of non-viral gene therapy treatments, to transform the life of patients suffering from rare and more prevalent diseases.